Michel Dahan, SVP, COO: Akebia Therapeutics AKBA Sell · Filed 23/03/01

Trade details

Type: Insider sale
Amount: $8,172.9
Shares · price: 10,090 sh · $0.81 a share
Held after: 289,927 sh
Stock: Akebia Therapeutics AKBA
Person: Michel DahanSVP, COO
Trade date: 23/02/27
Filed: 23/03/01
Days to filing: 2 days

Sold 3.4% of holdings

Share of holding sold: 3.4%

Akebia Therapeutics trades, last 26 weeks

What else happened in Akebia Therapeutics around then

Filed or reported within 30 days of the trade day · 23/01/28~23/03/29

Michel Dahan's recent trades

Michel DahanSVP, COO
Sell10b5-1 planAkebia Therapeutics
Sell10b5-1 plan
Akebia Therapeutics
AKBA
$43.9K
34,840 sh
$43.9K
Filed 24/05/14
Traded 24/05/13
Michel DahanSVP, COO
SellAkebia Therapeutics
Sell
Akebia Therapeutics
AKBA
$13.7K
8,661 sh
$13.7K
Filed 24/03/01
Traded 24/02/29
Michel DahanSVP, COO
SellAkebia Therapeutics
Sell
Akebia Therapeutics
AKBA
$16.3K
10,744 sh
$16.3K
Filed 24/02/29
Traded 24/02/27
Michel DahanSVP, COO
SellAkebia Therapeutics
Sell
Akebia Therapeutics
AKBA
$116.5K
95,478 sh
$116.5K
Filed 23/05/25
Traded 23/05/25
Michel DahanSVP, COO
SellAkebia Therapeutics
Sell
Akebia Therapeutics
AKBA
$1,653
1,878 sh
$1,653
Filed 23/03/03
Traded 23/03/01